Evaluation of Neck Masses in Adults

Jason Wilbur, MD
Valery L. Tran, MD
Marc F. Doobay, MPAS, PA-C

American Family Physician. 2026;113(2):156-165.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

Neck masses are common in the outpatient setting. Although the differential diagnosis is broad, 95% of neck masses are benign. Efficiently identifying malignant masses is a priority. An investigatory framework allows for accurate diagnosis without delays in care. Human papillomavirus–related oropharyngeal squamous cell carcinoma constitutes approximately 70% of new head and neck cancer diagnoses. The differential diagnosis of a neck mass can be divided into three categories based on acuity: acute (eg, infection), subacute (eg, malignancy), and chronic (eg, congenital, thyroid). When a diagnosis cannot be made by history, risk factors, and physical examination alone, imaging or biopsy is indicated. Contrast-enhanced computed tomography is recommended for most nonpulsatile, nonthyroid masses. For thyroid masses, ultrasonography is the imaging modality of choice. Contrast-enhanced magnetic resonance imaging, computed tomography angiography, and positron emission tomography are preferred in cases of cranial nerve involvement, pulsatile masses, and potential metastases, respectively. When biopsy is indicated, fine-needle aspiration is recommended. In the detection of malignancy, fine-needle aspiration has an accuracy of 93%, sensitivity of 90%, and specificity of 97%, regardless of anatomic site.

JASON WILBUR, MD, FAAFP, is a clinical professor and vice chair for education, Department of Family and Community Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City.

VALERY L. TRAN, MD, is a clinical assistant professor, Department of Family and Community Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City.

MARC F. DOOBAY, MPAS, PA-C, is a clinical assistant professor, Department of Family and Community Medicine, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City.

Address correspondence to Jason Wilbur, MD, FAAFP, at jason-wilbur@uiowa.edu.

Author disclosure: No relevant financial relationships.

  1. 1.Kshirsagar RS, Anderson M, Boeckermann LM, et al. The adult neck mass: predictors of malignancy. Otolaryngol Head Neck Surg. 2021;165(5):673-681.
  2. 2.Pynnonen MA, Gillespie MB, Roman B, et al. Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngol Head Neck Surg. 2017;157(2 suppl):S1-S30.
  3. 3.Haynes J, Arnold KR, Aguirre-Oskins C, et al. Evaluation of neck masses in adults. Am Fam Physician. 2015;91(10):698-706.
  4. 4.Kim MJ, Milliren A, Gerold DJ. Salivary gland disorders: rapid evidence review. Am Fam Physician. 2024;109(6):550-559.
  5. 5.Rosenberg TL, Brown JJ, Jefferson GD. Evaluating the adult patient with a neck mass. Med Clin North Am. 2010;94(5):1017-1029.
  6. 6.Aulino JM, Kirsch CFE, Burns J, et al.; Expert Panel on Neurologic Imaging. ACR Appropriateness Criteria neck mass-adenopathy. J Am Coll Radiol. 2019;16(5S):S150-S160.
  7. 7.Al-Dajani N, Wootton SH. Cervical lymphadenitis, suppurative parotitis, thyroiditis, and infected cysts. Infect Dis Clin North Am. 2007;21(2):523-541.
  8. 8.Heikkinen T, Järvinen A. The common cold. Lancet. 2003;361(9351):51-59.
  9. 9.Liao DZ, Schlecht NF, Rosenblatt G, et al. Association of delayed time to treatment initiation with overall survival and recurrence among patients with head and neck squamous cell carcinoma in an underserved urban population. JAMA Otolaryngol Head Neck Surg. 2019;145(11):1001-1009.
  10. 10.Cataño JC, Robledo J. Tuberculous lymphadenitis and parotitis. Microbiol Spectr. 2016;4(6).
  11. 11.Sharma S, Hashmi MF, Valentino DJ 3rd. Actinomycosis. StatPearls Publishing; August 7, 2023.
  12. 12.Pfister DG, Spencer S, Adelstein D, et al. Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2020;18(7):873-898.
  13. 13.Feier J, Self Q, Karabachev A, et al. Assessing the role of ultrasound for the evaluation of adult neck masses. Laryngoscope Investig Otolaryngol. 2022;8(1):135-139.
  14. 14.Lee J, Fernandes R. Neck masses: evaluation and diagnostic approach. Oral Maxillofac Surg Clin North Am. 2008;20(3):321-337.
  15. 15.Saraiya M, Unger ER, Thompson TD, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015;107(6):djv086.
  16. 16.US Cancer Statistics Working Group. US cancer statistics data visualizations tool. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; June 2024. Accessed February 10, 2025. https://www.cdc.gov/cancer/dataviz
  17. 17.Koch WM. Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up. Otolaryngol Clin North Am. 2012;45(4):779-793.
  18. 18.Andrews PJ, Giddings CEB, Su AP. Management of lateral cystic swellings of the neck, in the over 40s′ age group. J Laryngol Otol. 2003;117(4):318-320.
  19. 19.Crozier E, Sumer BD. Head and neck cancer. Med Clin North Am. 2010;94(5):1031-1046.
  20. 20.Atkinson K, Austin DE, McElwain TJ, et al. Alcohol pain in Hodgkin's disease. Cancer. 1976;37(2):895-899.
  21. 21.Knopf A, Bas M, Chaker A, et al. Rheumatic disorders affecting the head and neck: underestimated diseases. Rheumatology (Oxford). 2011;50(11):2029-2034.
  22. 22.Thakral B, Zhou J, Medeiros LJ. Extranodal hematopoietic neoplasms and mimics in the head and neck: an update. Hum Pathol. 2015;46(8):1079-1100.
  23. 23.Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1-133.
  24. 24.Bonnema SJ, Hegedus L. Nontoxic goiter. In: Vitti P, Hegedüs L, eds. Thyroid Diseases: Pathogenesis, Diagnosis, and Treatment (Endocrinology). Springer; 2018.
  25. 25.Montanelli L, Benvenga S, Hegedüs L, et al. Drugs and other substances interfering with thyroid function. In: Vitti P, Hegedüs L, eds. Thyroid Diseases: Pathogenesis, Diagnosis, and Treatment (Endocrinology). Springer; 2018.
  26. 26.Kant R, Davis A, Verma V. Thyroid nodules: advances in evaluation and management. Am Fam Physician. 2020;102(5):298-304.
  27. 27.Vazquez Salas S, Pedro K, Balram A, et al. Head and neck cystic lesions: a cytology review of common and uncommon entities. Acta Cytol. 2022;66(5):359-370.
  28. 28.El-Monem MH, Gaafar AH, Magdy EA. Lipomas of the head and neck: presentation variability and diagnostic work-up. J Laryngol Otol. 2006;120(1):47-55.
  29. 29.Smith MM, Abrol A, Gardner GM. Assessing delays in laryngeal cancer treatment. Laryngoscope. 2016;126(7):1612-1615.
  30. 30.Bruun JP. Time lapse by diagnosis of oral cancer. Oral Surg Oral Med Oral Pathol. 1976;42(2):139-149.
  31. 31.Hoang JK, Oldan JD, Mandel SJ, et al.; Expert Panel on Neurological Imaging. ACR Appropriateness Criteria thyroid disease. J Am Coll Radiol. 2019;16(5S):S300-S314.
  32. 32.Schwetschenau E, Kelley DJ. The adult neck mass. Am Fam Physician. 2002;66(5):831-839.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.